About PROJENX INC
ProJenX is a biotechnology company focused on developing prosetin, a novel CNS-penetrant MAP4K inhibitor, for the treatment of ALS and other neurodegenerative diseases. The company was founded through a long-term collaboration between Project ALS and Columbia University researchers.
Development of novel, brain-penetrant kinase inhibitorsUtilization of patient-derived laboratory models for drug discoveryClinical trial development and executionCollaboration with leading research institutions and physician-scientists
Is this your company?
Claim PROJENX INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim PROJENX INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.